Cadila buys JV partner's 50 pc stake in Zydus BSV PharmaZydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).
26 Mar, 2015, 06.38 PM IST
Wockhardt gets USFDA approval for anti-ulcer drugDrug firm Wockhardt today said it has received approval from American health regulator to market Lansoprazole, a drug used in treatment of ...
17 Sep, 2012, 03.42 PM IST
- Wockhardt gets USFDA nod for generic Uroxatral
Wockhardt today said it has received approval from the American health regulator USFDA to market Alfuzosin hydrochloride tablets.
14 Aug, 2012, 04.05 PM IST
- Venus Remedies launches pain killer injection in domestic mkt
Drug firm Venus Remedies today said it has launched its 'Achnil' injection, a pain killer, in the country's pharmaceutical market.
11 Jul, 2011, 02.53 PM IST
- Lincoln Pharma gets patent approval for nasal spray treatment
Lincoln Pharmaceuticals on Monday said it has received patent approval for a nasal spray, which would help prevent vomiting and nausea.
17 Jan, 2011, 05.05 PM IST
- Elder Pharma to strengthen position in womencare, neutraceutical segments
The company aims to increase its reach and market share in the two segments, both through in-licensing products and its own products.
17 Jun, 2010, 12.30 PM IST
- Elder enters nutraceutical segement, develops first drug
The latest to join the nutraceutical business is the Mumbai-based Rs 600-crore company Elder Pharmaceuticals, which has just developed its ...
20 May, 2010, 12.33 AM IST
- Zydus Healthcare launches NDDS product Nudoxa
Zydus Cadila has introduced an NDDS product for treatment of various types of cancer, which is stable and long lasting with reduced toxicit...
15 Feb, 2008, 11.06 AM IST
- Pharma companies demerging NCE, NDDS operations
Pharma majors are de-merging their NCE operations into separate cos to scale-up their activities and achieve better focus. Drug cos in pric...
18 Nov, 2007, 05.23 AM IST
- Ranbaxy forays into authorised generics in US
Pharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR - an anti h...
30 Jul, 2007, 05.10 PM IST
- Panacea Biotec to enter oncology segment
Biotech firm Panacea Biotec on Thursday said it is planning to foray into oncology segment.
28 Jun, 2007, 08.10 PM IST
- Alembic signs licensing agreement with UCB
Alembic today said it has signed $11 million licensing agreement with Belgium-based UCB for anti-epileptic drug Keppra.
23 May, 2007, 09.10 PM IST
- Indoco set to board NDDS platform
Mid-sized pharma company Indoco Remedies plans to start manufacturing novel drugs under the novel drug delivery system (NDDS) platform.
09 Apr, 2007, 01.35 AM IST
- Ranbaxy unveils two new drugs
Ranbaxy Labs on Monday announced the launch of two Novel Drug Delivery System (NDDS) products in the Urology Segment. Niftran 100mg Capsule...
29 Jan, 2007, 09.00 PM IST
- NPIL expects Rs 1,000 cr revenue
As the costs of medicines are high abroad, the MNCs need Indian companies to manufacture their products.
29 Sep, 2006, 06.50 PM IST
- Lincoln's patent on 'Vivian Roll On' accepted
Pharmaceutical company, Lincoln Pharmaceuticals Ltd on Thursday said its application for the patent of Vivian Roll On, the composition comp...
21 Sep, 2006, 04.00 PM IST
- Wockhardt gets nod for new drug
Wockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
14 Jun, 2006, 02.40 PM IST